www.zerohedge.com

Lilly's Weight-Loss Pill Data Achieves "Best-Case Scenario", Sending Rival Novo Shares Into Abyss | ZeroHedge

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero